Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia (Q35051430)

6 August 2017

Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia (English)

1 reference

6 August 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

12

Zhigang Li

1 reference

6 August 2017

Yanyan Mei

1

1 reference

6 August 2017

Chao Gao

2

1 reference

6 August 2017

Kailing Wang

3

1 reference

6 August 2017

Lei Cui

4

1 reference

6 August 2017

Weijing Li

5

1 reference

6 August 2017

Xiaoxi Zhao

6

1 reference

6 August 2017

Feifei Liu

7

1 reference

6 August 2017

Minyuan Wu

8

1 reference

6 August 2017

Guoren Deng

9

1 reference

6 August 2017

Wei Ding

10

1 reference

6 August 2017

Hongti Jia

11

1 reference

6 August 2017

30 March 2014

1 reference

6 August 2017

1 reference

6 August 2017

105

1 reference

6 August 2017

4

1 reference

6 August 2017

463-472

1 reference

miR-210 is a target of hypoxia-inducible factors 1 and 2 in renal cancer, regulates ISCU and correlates with good prognosis.

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Monoclonal antibody-based therapies: a new dawn in the treatment of acute lymphoblastic leukemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

High expression of miR-210 predicts poor survival in patients with breast cancer: a meta-analysis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

The tumor suppressor HINT1 regulates MITF and β-catenin transcriptional activity in melanoma cells.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

miR-210: the master hypoxamir

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

miR-210: More than a silent player in hypoxia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Recent research advances in childhood acute lymphoblastic leukemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MicroRNA-210 as a novel therapy for treatment of ischemic heart disease

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MiR-210--micromanager of the hypoxia pathway

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Circulating miR-210 as a Novel Hypoxia Marker in Pancreatic Cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MicroRNA-210: a unique and pleiotropic hypoxamir

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Role of microRNAs in drug-resistant ovarian cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Bone-marrow relapse in paediatric acute lymphoblastic leukaemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Silencing of microRNAs in vivo with 'antagomirs'

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Pediatric acute lymphoblastic leukemia

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4317805

Expression of microRNA 210 associates with poor survival and age of tumor onset of soft-tissue sarcoma patients

8 July 2018

1 reference

CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia.

21 January 2018

1 reference

Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.

21 January 2018

1 reference

Real-time quantitative RT-PCR: design, calculations, and statistics.

21 January 2018

1 reference

Classification of pediatric acute lymphoblastic leukemia by gene expression profiling

21 January 2018

1 reference

Modulation of membrane rigidity by the human vesicle trafficking proteins Sar1A and Sar1B

21 January 2018

1 reference

Expression of Sar1b enhances chylomicron assembly and key components of the coat protein complex II system driving vesicle budding.

21 January 2018

1 reference

Variable phenotypic expression of chylomicron retention disease in a kindred carrying a mutation of the Sara2 gene.

21 January 2018

1 reference

Loss-of-function mutations in HINT1 cause axonal neuropathy with neuromyotonia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/CAS.12370

1 reference

6 August 2017

1 reference

6 August 2017

1 reference